CompletedPhase 1

Efficacy and Safety of Milrinone Versus Sildenafil in the Treatment of Neonates With Persistent Pulmonary Hypertension

40 participantsStarted 2015-01

Plain-language summary

Compare the effect of milrinone versus sildenafil in treatment of neonates with persistent pulmonary hypertension.

Who can participate

Age range1 Hour – 10 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * gestational age \>34 weeks * postnatal age \<10 days Exclusion Criteria: * neonates with congenital heart disease * neonates with congenital diaphragmatic hernia

What they're measuring

efficacy of milrinone versus sildenafil in treatment of PPHN

Timeframe: 6 - 12 months

Trial details

NCT IDNCT04391478

SponsorRania Ali El-Farrash

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-04

View on ClinicalTrials.gov More Persistent Pulmonary Hypertension trials